---
title: "Stock Market Today: April 17, 2020"
description: As the week concludes, and after yesterday's volatility and key housing news, the day ahead should bring more earnings reports and further market gyrations. To this point, the indications are that stocks will open strongly to the upside on better-than-expected GDP data out of China and on encouraging drug possibilities on the COVID-19 front from Gilead Sciences (GILD) when trading resumes. One data point to watch for in the coming minutes will be the report on the leading economic indicators.
image: https://investor.valueline.com/hubfs/social-suggested-images/iStock_000006488152XSmall-443.jpg
---

[![The Value Line Blog](https://investor.valueline.com/hubfs/VL%20Blog%20Images/vl_blog_header.png)](https://investor.valueline.com/blog)

[Stock Market Today](https://investor.valueline.com/blog/topic/stock-market-today)

# Stock Market Today: April 17, 2020

 April 17, 2020

### **Before The Bell**

Wall Street began yesterday's session, following a weaker performance on Wednesday, with some early losses, especially in the Dow Jones Industrial Average. The initial pullback, which would carry the blue chips to a loss of close to 300 points in the first half hour, came on the heels of the release of some disheartening economic news. First, the Commerce Department reported that housing starts had tumbled 22.3% in May, while building permits, a more forward-looking metric, fell just 6.8%.

More worrisome, and perhaps more indicative of the current dour business outlook, would be the Labor Department's data showing that unemployment claims had swelled by 5.245 million in the latest week. That was the fourth staggering increase in as many weeks. In all, the job losses in that relatively brief span total 22.025 million. That loss nearly matches the 22.442 million positions added since the end of the last recession in 2009. In the meantime, the latest tally was modestly above the forecast loss of 5.1 million jobs.

The weak jobs number was an offsetting influence on market trading with the Administration's efforts to restart at least part of the economy in the next few weeks. Meantime, as the morning moved along, the bulls would begin to make their move, and as we passed the 90-minute trading mark, the Dow had erased nearly all of its early losses, while the NASDAQ, which had been in the plus column almost throughout the morning was adding to its initial gains, and was boasting a 125-point advance on strength in technology.

All the while, first-quarter earnings continued to come out and, for the most part, they were not making good reading, with Morgan Stanley ([MS](https://research.valueline.com/research#sec=company&sym=MS)) among the headline casualties, as the investment banking giant reported a drop in earnings and warned of more difficult times ahead. Then, as the afternoon began, the bears returned to take the reins, albeit very briefly, as the Dow again fell to near session lows. But that was a short-lived affair, and stocks continued their recovery through the remainder of the afternoon.

The comeback would be led by the NASDAQ, with a 100-point surge in shares of Amazon.com ([AMZN](https://research.valueline.com/research#list=recent&sec=company&sym=amzn)) leading the group. That behemoth, now selling for $2,400 a share, is benefiting from the inability of consumers to shop off line. Shares of Netflix ([NFLX](https://research.valueline.com/research#list=recent&sec=company&sym=nflx)) also gained, as many more Americans, unable to attend movies or shows, are opting for movies at home. In all, the Dow would climb just 33 points, but the NASDAQ would surge by 139 points and the S&P 500 would add 16 points. Small caps would lag, however, with the Russell 2000 easing a bit.

Now, the week concludes, and after yesterday's volatility and key housing news, the day ahead should bring more earnings reports and further market gyrations. To this point, the indications are that stocks will open strongly to the upside on better-than-expected GDP data out of China and on encouraging drug possibilities on the COVID-19 front from Giliead ([GILD](https://research.valueline.com/research#list=recent&sec=company&sym=gild)) when trading resumes. One data point to watch for in the coming minutes will be the report on the leading economic indicators.

- Harvey S. Katz, CFA

*At the time of this article's writing, the author did not have positions in any of the companies mentioned.*

[![Register now for our free One Stock to Buy webinar](https://no-cache.hubspot.com/cta/default/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5.png)](https://cta-redirect.hubspot.com/cta/redirect/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5)

### Popular Posts

Search

Search Blog

### Topics

- [Investing 101 (2)](https://investor.valueline.com/blog/topic/investing-101)
- [Market Commentary (37)](https://investor.valueline.com/blog/topic/market-commentary)
- [Stock Highlights (390)](https://investor.valueline.com/blog/topic/stock-highlights)
- [Stock Market Today (2071)](https://investor.valueline.com/blog/topic/stock-market-today)

 Copyright 2026 Value Line, Inc. All Rights Reserved. Factual material is obtained from sources believed to be reliable and is provided without warranties of any kind. VALUE LINE IS NOT RESPONSIBLE FOR ANY ERRORS OR OMISSIONS HEREIN OR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. This blog is strictly for subscriber's own, non-commercial, internal use. No part of it may be reproduced, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product. Officers, directors, or employees of Value Line, Inc. and its affiliates and subsidiaries, and EULAV Asset Management, may own stocks that are featured in this email. Nothing herein should be construed as an offer to buy or sell securities or to give individual investment advice. Value Line, the Value Line logo, The Most Trusted Name in Investment Research, “Smart research. Smarter investing.”, The Value Line Investment Survey, Timeliness, and Safety are trademarks or registered trademarks of Value Line, Inc. and/or its affiliates in the United States and other countries.